Here's Why You Should Retain Glaukos (GKOS) Stock for Now
https://www.zacks.com/stock/news/2282964/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2282964
Jun 03, 2024 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
0
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2282887/three-reasons-to-retain-bd-bdx-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2282887
Jun 03, 2024 - BD's (BDX) robust product portfolio raises optimism about the stock.
0
Patterson Companies' (PDCO) New Launch to Boost Patient Service
https://www.zacks.com/stock/news/2282875/patterson-companies-pdco-new-launch-to-boost-patient-service?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2282875
Jun 03, 2024 - Patterson Companies' (PDCO) Patterson CarePay+ is likely to improve overall patient care and streamline practice operations.
0
ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment
https://www.zacks.com/stock/news/2282872/clearpoint-s-clpt-new-products-to-boost-neurosurgical-segment?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2282872
Jun 03, 2024 - ClearPoint (CLPT) announces the full market release of the SmartFrame OR platform, intended for performing DBS, and Prism Neuro Laser Therapy System for providing thermal therapy.
0
New Gold (NGD) Hits 52-Week High: What's Aiding the Stock?
https://www.zacks.com/stock/news/2282300/new-gold-ngd-hits-52-week-high-what-s-aiding-the-stock?cid=CS-ZC-FT-analyst_blog|52week_high/low-2282300
May 31, 2024 - New Gold (NGD) gains from ongoing exploration efforts and an upbeat outlook.
0
Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M
https://www.zacks.com/stock/news/2282291/surmodics-srdx-enters-deal-to-be-acquired-by-gtcr-for-627m?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2282291
May 31, 2024 - Surmodics (SRDX) enters a definitive agreement to be acquired by renowned private equity company GTCR at an estimated total equity valuation of $627 million.
0
BHP Group (BHP) Drops Acquisition Plan for Anglo American
https://www.zacks.com/stock/news/2282074/bhp-group-bhp-drops-acquisition-plan-for-anglo-american?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2282074
May 31, 2024 - BHP Group (BHP) resolves not to make any further offer for Anglo American, thus walking away from a deal that would have been the biggest mining deal in a decade.
0
What Makes Axalta Coating (AXTA) a Solid Choice Right Now
https://www.zacks.com/stock/news/2282082/what-makes-axalta-coating-axta-a-solid-choice-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2282082
May 31, 2024 - Axalta Coating (AXTA) looks promising at the moment based on its robust Q1 results and the acquisition of The CoverFlexx Group.
0
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now
https://www.zacks.com/stock/news/2281627/here-s-why-you-should-add-lantheus-lnth-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2281627
May 30, 2024 - Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
0
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
https://www.zacks.com/stock/news/2281466/reasons-why-you-should-retain-avantor-avtr-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2281466
May 30, 2024 - Avantor's (AVTR) strong product portfolio raises optimism about the stock.
0